<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03237247</url>
  </required_header>
  <id_info>
    <org_study_id>17100256</org_study_id>
    <nct_id>NCT03237247</nct_id>
  </id_info>
  <brief_title>Role of Complete Blood Picture in Predicting the Etiology of Extrahepatic Cholestasis</brief_title>
  <official_title>Role of Complete Blood Picture in Predicting the Etiology of Extrahepatic Cholestasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cases with extrahepatic cholestasis are common and faced during day to day clinical practice,
      however reaching the final etiology is sometimes challenging and needs investigations which
      are usually expensive, may carry hazards to the patients, or inaccessible so we are in need
      for a method which is easily available, affordable and safe for aiding in the differential
      diagnosis of extrahepatic cholestasis. our study aiming to evaluate the role of complete
      blood count in predicting the etiology of extrahepatic cholestasis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extrahepatic cholestasis has various etiologies including benign causes (benign stricture,
      chronic pancreatitis, choledochal cyst, mirizzi syndrome, etc...), choledocholithiasis,
      malignant causes (cancer pancreas, gallbladder cancer, cholangiocarcinoma, etc....),
      parasitic infestations (fasciola hepatica, ascaris lumbricoides, etc......) and other causes.
      it is essential to detect the exact cause of extrahepatic cholestasis in order to determine
      treatment options. diagnosing such conditions depends on clinical examination, laboratory
      investigations, imaging studies, endoscopic procedures, biopsy and even surgical
      intervention. some of these investigations are expensive, not available, or carry risk to the
      patients. moreover non of them is accurate 100%. Complete blood count is already available,
      easy to obtain, not invasive investigation. In these study we are trying to evaluate the role
      of complete blood count parameters namely RDW, MPV, PDW, PCT, NLR, PLR in the differential
      diagnosis of extrahepatic cholestasis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2016</start_date>
  <completion_date type="Actual">February 28, 2017</completion_date>
  <primary_completion_date type="Actual">February 28, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>differential diagnosis of extrahepatic cholestasis</measure>
    <time_frame>10 days</time_frame>
    <description>complete blood count parameters</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">38</enrollment>
  <condition>Extrahepatic Cholestasis</condition>
  <arm_group>
    <arm_group_label>Benign</arm_group_label>
    <description>cases with benign biliary stricture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcular OJ</arm_group_label>
    <description>cases with calcular extrahepatic cholestasis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Malignant Distal</arm_group_label>
    <description>cases with malignant distal extrahepatic cholestasis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Malignant Proximal</arm_group_label>
    <description>cases with malignant proximal extrahepatic cholestasis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrahepatic</arm_group_label>
    <description>cases with intrahepatic cholestasis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients with extrahepatic cholestasis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with extrahepatic cholestasis

        Exclusion Criteria:

          -  age under 14 years

          -  previous bilio-pancreatic interventions

          -  hemoglobinopathy

          -  splenomegaly

          -  myeloproliferative disorders

          -  diabetes mellitus

          -  recent blood transfusion in less than one month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2017</study_first_submitted>
  <study_first_submitted_qc>July 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2017</study_first_posted>
  <last_update_submitted>August 7, 2017</last_update_submitted>
  <last_update_submitted_qc>August 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Wael M Sayed</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <keyword>extrahepatic cholestasis, CBC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Cholestasis, Extrahepatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

